Viatris EBITDA Margin 2010-2025 | VTRS

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Viatris (VTRS) over the last 10 years. The current EBITDA margin for Viatris as of March 31, 2025 is .
Viatris EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $14.33B $2.73B 19.03%
2024-12-31 $14.74B $2.90B 19.70%
2024-09-30 $15.05B $2.53B 16.79%
2024-06-30 $15.24B $2.76B 18.12%
2024-03-31 $15.36B $3.27B 21.30%
2023-12-31 $15.43B $3.51B 22.73%
2023-09-30 $15.47B $3.99B 25.77%
2023-06-30 $15.60B $4.11B 26.37%
2023-03-31 $15.80B $4.33B 27.40%
2022-12-31 $16.26B $4.64B 28.54%
2022-09-30 $16.73B $4.65B 27.77%
2022-06-30 $17.19B $4.76B 27.70%
2022-03-31 $17.65B $4.76B 26.96%
2021-12-31 $17.89B $4.47B 25.00%
2021-09-30 $17.17B $3.87B 22.55%
2021-06-30 $15.60B $3.28B 21.03%
2021-03-31 $13.76B $2.56B 18.62%
2020-12-31 $11.95B $2.01B 16.79%
2020-09-30 $11.51B $2.75B 23.92%
2020-06-30 $11.50B $2.76B 24.02%
2020-03-31 $11.63B $2.81B 24.17%
2019-12-31 $11.50B $2.74B 23.78%
2019-09-30 $11.39B $2.76B 24.21%
2019-06-30 $11.29B $2.80B 24.83%
2019-03-31 $11.25B $2.89B 25.67%
2018-12-31 $11.43B $3.02B 26.38%
2018-09-30 $11.59B $3.12B 26.90%
2018-06-30 $11.72B $3.04B 25.94%
2018-03-31 $11.87B $3.25B 27.41%
2017-12-31 $11.91B $3.24B 27.23%
2017-09-30 $11.94B $3.09B 25.87%
2017-06-30 $12.01B $2.64B 22.01%
2017-03-31 $11.61B $2.46B 21.21%
2016-12-31 $11.08B $2.22B 20.06%
2016-09-30 $10.30B $2.20B 21.33%
2016-06-30 $9.94B $2.74B 27.58%
2016-03-31 $9.75B $2.56B 26.28%
2015-12-31 $9.43B $2.49B 26.44%
2015-09-30 $9.02B $2.29B 25.37%
2015-06-30 $8.41B $2.06B 24.48%
2015-03-31 $7.88B $1.88B 23.86%
2014-12-31 $7.72B $1.92B 24.86%
2014-09-30 $7.45B $1.77B 23.81%
2014-06-30 $7.13B $1.61B 22.60%
2014-03-31 $6.99B $1.68B 24.06%
2013-12-31 $6.91B $1.65B 23.91%
2013-09-30 $6.82B $1.63B 23.86%
2013-06-30 $6.86B $1.67B 24.30%
2013-03-31 $6.85B $1.62B 23.73%
2012-12-31 $6.80B $1.66B 24.35%
2012-09-30 $6.61B $1.64B 24.77%
2012-06-30 $6.38B $1.54B 24.09%
2012-03-31 $6.27B $1.56B 24.88%
2011-12-31 $6.13B $1.52B 24.73%
2011-09-30 $6.03B $1.35B 22.39%
2011-06-30 $5.81B $1.28B 22.08%
2011-03-31 $5.61B $1.17B 20.94%
2010-12-31 $5.45B $1.14B 20.99%
2010-09-30 $5.37B $1.10B 20.51%
2010-06-30 $5.28B $0.93B 17.57%
2010-03-31 $5.18B $0.90B 17.45%
2009-12-31 $5.09B $0.92B 18.14%
Sector Industry Market Cap Revenue
Medical Medical Services $10.469B $14.739B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.613B 26.94
Elevance Health (ELV) United States $86.883B 11.21
CVS Health (CVS) United States $85.338B 10.61
Cencora (COR) United States $57.283B 19.93
DiDi Global (DIDIY) China $22.826B 24.25
Natera (NTRA) United States $22.577B 0.00
Labcorp Holdings (LH) United States $21.856B 17.73
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.669B 0.00
Solventum (SOLV) United States $12.768B 13.52
ICON (ICLR) Ireland $11.763B 10.94
CochLear (CHEOY) Australia $11.550B 0.00
Revvity (RVTY) United States $11.024B 18.97
Doximity (DOCS) United States $10.503B 48.63
HealthEquity (HQY) United States $9.059B 39.68
Avantor (AVTR) United States $8.906B 12.94
Medpace Holdings (MEDP) United States $8.572B 22.77
Sonic Healthcare (SKHHY) Australia $8.393B 0.00
Charles River Laboratories (CRL) United States $7.340B 14.38
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.361B 25.69
BrightSpring Health Services (BTSG) United States $3.724B 34.16
Sotera Health (SHC) United States $3.244B 18.43
Alignment Healthcare (ALHC) United States $2.956B 0.00
Surgery Partners (SGRY) United States $2.914B 37.90
Concentras Parent (CON) United States $2.749B 15.89
Organon (OGN) United States $2.610B 2.77
Ardent Health (ARDT) United States $1.881B 8.02
Premier (PINC) United States $1.858B 14.11
GeneDx Holdings (WGS) United States $1.842B 70.96
Progyny (PGNY) United States $1.803B 39.68
PACS (PACS) United States $1.573B 0.00
GoodRx Holdings (GDRX) United States $1.561B 31.21
Teladoc Health (TDOC) United States $1.203B 0.00
Pediatrix Medical (MD) United States $1.203B 9.15
Establishment Labs Holdings (ESTA) $1.083B 0.00
CareDx (CDNA) United States $1.035B 16.17
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.890B 0.00
AMN Healthcare Services Inc (AMN) United States $0.826B 7.73
QDM (QDMI) Hong Kong, SAR China $0.763B 0.00
Nutex Health (NUTX) United States $0.679B 10.28
LifeMD (LFMD) United States $0.566B 0.00
Embecta (EMBC) United States $0.559B 3.76
Enhabit (EHAB) United States $0.495B 40.75
InnovAge Holding (INNV) United States $0.478B 0.00
Auna S.A (AUNA) Luxembourg $0.467B 10.52
SBC Medicals (SBC) United States $0.459B 0.00
Sonida Senior Living (SNDA) United States $0.453B 0.00
Omada Health (OMDA) $0.440B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.411B 0.00
Performant Healthcare (PHLT) United States $0.255B 0.00
Oncology Institute (TOI) United States $0.220B 0.00
Beauty Health (SKIN) United States $0.193B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.148B 24.17
Pheton Holdings (PTHL) China $0.114B 0.00
So-Young (SY) China $0.097B 0.00
KindlyMD (NAKA) United States $0.083B 0.00
OncoCyte (OCX) United States $0.076B 0.00
Sera Prognostics (SERA) United States $0.064B 0.00
Basel Medical Group (BMGL) Singapore $0.064B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
Biodesix (BDSX) United States $0.042B 0.00
ModivCare (MODV) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00